Concourse Financial Group Securities’s Genomic Health, Inc. GHDX Stock Holding History

Concourse Financial Group Securities’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29	Closed	-$1.97K	–	2182
2019 Q3	$2K	Sell	29 -14	-33%	-$961	﹤0.01%	1605
2019 Q2	$3K	Sell	43 -8	-16%	-$474	﹤0.01%	1951
2019 Q1	$3K	Sell	51 -13	-20%	-$964	﹤0.01%	1982
2018 Q4	$4K	Buy	64 +29	+83%	+$2.03K	﹤0.01%	1785
2018 Q3	$2K	Buy	+35	New	+$2.05K	﹤0.01%	1594

Concourse Financial Group Securities's GHDX Position: Q4 2019 in Review

Concourse Financial Group Securities sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 29 shares — an estimated $1.97K sold.

Concourse Financial Group Securities first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $4K in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Concourse Financial Group Securities reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Concourse Financial Group Securities sold 29 Genomic Health, Inc. shares in Q4 2019, an estimated $1.97K.
Concourse Financial Group Securities first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Concourse Financial Group Securities's Genomic Health, Inc. position peaked at $4K in Q4 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Concourse Financial Group Securities's 13F filing for Q4 2019, filed 14 Feb 2020.